$36.79 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Luminex

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Stock Analysis

last close $36.92
1-mo return 0.7%
3-mo return 9.4%
avg daily vol. 445.56T
52-week high 41.69
52-week low 20.61
market cap. $1.7B
forward pe 37.9
annual div. 0.4
roe 4.9%
ltg forecast -
dividend yield 1.08%
annual rev. $438M
inst own. 92.3%

Subscribe now for daily local and international financial news